SAMHD1: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
 
CSV import
 
Line 1: Line 1:
{{Infobox protein
== SAMHD1 ==
| name = SAMHD1
| image = SAMHD1_structure.png
| caption = Crystal structure of SAMHD1
| symbol = SAMHD1
| HGNCid = 18220
| OMIM = 606754
| EntrezGene = 25939
| RefSeq = NM_015474
| UniProt = Q9Y3Z3
}}


'''SAMHD1''' (''SAM domain and HD domain-containing protein 1'') is a human protein encoded by the '''SAMHD1''' gene. It is a deoxynucleotide triphosphohydrolase (dNTPase) that plays a crucial role in the regulation of intracellular deoxynucleotide triphosphate (dNTP) levels and has been implicated in the restriction of HIV-1 replication in certain immune cells.
'''SAMHD1''' is a protein encoded by the '''SAMHD1 gene''' in humans. It is a member of the HD domain superfamily and is involved in the regulation of the innate immune response. SAMHD1 is known for its role in restricting the replication of [[HIV-1]] in certain immune cells, such as [[dendritic cells]], [[macrophages]], and [[resting CD4+ T cells]].


==Structure==
== Function ==
SAMHD1 is composed of 626 amino acids and contains two main domains: the sterile alpha motif (SAM) domain and the histidine-aspartate (HD) domain. The SAM domain is involved in protein-protein interactions, while the HD domain is responsible for the enzymatic activity of the protein, specifically the hydrolysis of dNTPs into deoxynucleosides and inorganic triphosphate.


==Function==
SAMHD1 functions as a deoxynucleotide triphosphohydrolase (dNTPase), which means it hydrolyzes deoxynucleotide triphosphates (dNTPs) into deoxynucleosides and inorganic triphosphate. This activity reduces the intracellular pool of dNTPs, which are the building blocks for [[DNA synthesis]]. By depleting dNTPs, SAMHD1 limits the ability of [[retroviruses]] like HIV-1 to synthesize DNA and replicate within host cells.
SAMHD1 is primarily expressed in myeloid cells, such as dendritic cells and macrophages, as well as in resting CD4+ T cells. Its main function is to regulate the intracellular pool of dNTPs, which are the building blocks for DNA synthesis. By hydrolyzing dNTPs, SAMHD1 reduces their availability, thereby inhibiting the replication of retroviruses like HIV-1 that rely on these nucleotides for reverse transcription.


===Role in HIV-1 Restriction===
== Clinical Significance ==
SAMHD1 restricts HIV-1 replication by depleting the dNTP pool, which is essential for the reverse transcription of the viral RNA genome into DNA. This restriction is particularly effective in non-dividing cells, where dNTP levels are naturally low. The viral protein Vpx, found in some lentiviruses like HIV-2 and SIV, can counteract SAMHD1 by targeting it for proteasomal degradation, thereby allowing viral replication to proceed.


==Clinical Significance==
Mutations in the SAMHD1 gene have been associated with [[Aicardi-Goutières syndrome]], a rare genetic disorder that mimics [[congenital viral infection]] and is characterized by [[encephalopathy]], [[skin lesions]], and [[autoimmune]] phenomena. SAMHD1 mutations can lead to an accumulation of [[nucleic acids]] in cells, triggering an inappropriate immune response.
Mutations in the SAMHD1 gene have been associated with Aicardi-Goutières syndrome (AGS), a rare genetic disorder characterized by encephalopathy and an inappropriate immune response. SAMHD1 mutations can lead to an accumulation of intracellular dNTPs, resulting in increased DNA damage and an inflammatory response.


==Research and Therapeutic Implications==
== Research ==
Understanding the mechanism of SAMHD1-mediated HIV-1 restriction has potential therapeutic implications. Modulating SAMHD1 activity could enhance the innate immune response against HIV-1 or other viral infections. Additionally, SAMHD1's role in regulating dNTP levels makes it a potential target for cancer therapy, as many cancer cells have altered dNTP metabolism.


==Also see==
Research into SAMHD1 has expanded our understanding of its role in [[viral restriction]] and [[immune regulation]]. Studies have shown that SAMHD1 is involved in the response to [[DNA damage]] and may play a role in [[cancer]] biology. The protein's ability to regulate dNTP levels makes it a potential target for therapeutic interventions in diseases where dNTP balance is disrupted.
* [[HIV-1]]
 
== See Also ==
* [[HIV-1 restriction factors]]
* [[Innate immune system]]
* [[Aicardi-Goutières syndrome]]
* [[Aicardi-Goutières syndrome]]
* [[Deoxynucleotide triphosphate]]
 
* [[Vpx]]
== References ==
<references/>


{{Protein-stub}}
{{Protein-stub}}
{{HIV-1}}
{{Viral-stub}}


[[Category:Proteins]]
[[Category:Proteins]]
[[Category:Human genes]]
[[Category:Immunology]]
[[Category:Immunology]]
[[Category:Virology]]
[[Category:Virology]]

Latest revision as of 20:45, 30 December 2024

SAMHD1[edit]

SAMHD1 is a protein encoded by the SAMHD1 gene in humans. It is a member of the HD domain superfamily and is involved in the regulation of the innate immune response. SAMHD1 is known for its role in restricting the replication of HIV-1 in certain immune cells, such as dendritic cells, macrophages, and resting CD4+ T cells.

Function[edit]

SAMHD1 functions as a deoxynucleotide triphosphohydrolase (dNTPase), which means it hydrolyzes deoxynucleotide triphosphates (dNTPs) into deoxynucleosides and inorganic triphosphate. This activity reduces the intracellular pool of dNTPs, which are the building blocks for DNA synthesis. By depleting dNTPs, SAMHD1 limits the ability of retroviruses like HIV-1 to synthesize DNA and replicate within host cells.

Clinical Significance[edit]

Mutations in the SAMHD1 gene have been associated with Aicardi-Goutières syndrome, a rare genetic disorder that mimics congenital viral infection and is characterized by encephalopathy, skin lesions, and autoimmune phenomena. SAMHD1 mutations can lead to an accumulation of nucleic acids in cells, triggering an inappropriate immune response.

Research[edit]

Research into SAMHD1 has expanded our understanding of its role in viral restriction and immune regulation. Studies have shown that SAMHD1 is involved in the response to DNA damage and may play a role in cancer biology. The protein's ability to regulate dNTP levels makes it a potential target for therapeutic interventions in diseases where dNTP balance is disrupted.

See Also[edit]

References[edit]

<references/>


Stub icon
   This article is a protein-related stub. You can help WikiMD by expanding it!



Template:Viral-stub